Chetan C Oturkar - Department of Chemistry, University of Pune

基本信息

Career Trajectory

Bio

Chetan C Oturkar currently works at the Department of Clinical Pharmacology and Therapeutics, Roswell Park Cancer Institute. Chetan does research in Cancer Research. Their current project is 'Estrogen Receptors functions in Breast, Lung and Ovarian Cancer'.

Research Interests

Papers共 26 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Interaction Between Estrogen Receptors and P53: A Broader Role for Tamoxifen

Gokul M Das,Chetan C Oturkar, Vishnu Menon

Endocrinologyno. 3 (2025)

Cited0Views0WOSBibtex

Neoadjuvant tamoxifen therapy reactivates tumor suppressor protein p53 in luminal breast cancer patients: Results from a window-of-opportunity clinical trial

Gokul M. Das,Swati A. Kulkarni,Chetan Oturkar,Spencer Rosario,Stephen B. Edge,Jianmin Wang,Wendy M. Swetzig,Alan D. Hutson,Benny Kaipparettu,Adrienne Groman,Araba Adjei,Andrew K. Goey,Carl D. Morrison,Shicha Kumar

CANCER RESEARCHno. 5 (2023)

Cited0Views0Bibtex

Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant P53

Lauren Scarpetti,Chetan C. Oturkar,Dejan Juric,Maria Shellock,Giuliana Malvarosa,Kathryn Post,Steven Isakoff,Nancy Wang,Brian Nahed,Kevin Oh,Gokul M. Das,Aditya Bardia

The oncologist（2023）

Cited9Views0WOSBibtex

Abstract PD10-05: PD10-05 Neoadjuvant Tamoxifen Therapy Reactivates Tumor Suppressor Protein P53 in Luminal Breast Cancer Patients: Results from a Window-of-opportunity Clinical Trial

Cancer Research（2023）

Cited0Views0Bibtex

Combination of Tamoxifen and Doxorubicin Targets Estrogen Receptor Beta-Mutant P53-P73 Axis: A Novel Therapeutic Strategy for Triple Negative Breast Cancer

Gokul M. Das,Chetan C. Oturkar,Christina Adams,Jung H. Park,Melissa Dolan,Michalis Mastri, Manasori Oshi,Yoshihisa Tokumaru,Utpal K. Mukhopadhyay, Kalyani Abha,Kwang H. Jung,Sukjin Yang,Suna Kim,John Ebos,Kazuaki Takabe,Benny A. Kaipparettu

Cancer Researchno. 12_Supplement (2022): 3986-3986

Cited0Views0Bibtex

Estrogen Receptor-Beta2 (erβ2)–mutant P53–foxm1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)

Chetan C. Oturkar,Nishant Gandhi, Pramod Rao,Kevin H. Eng,Austin Miller,Prashant K. Singh,Emese Zsiros,Kunle O. Odunsi,Gokul M. Das

CANCERSno. 5 (2022)

Cited16Views0WOSBibtex

Estrogen Receptor-Alpha and P53 Status As Regulators of AMPK and Mtor in Luminal Breast Cancer

Nishant Gandhi,Chetan C. Oturkar,Gokul M. Das

Cancers（2021）

Cited5Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn